Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Robin E. Levitski x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To determine whether there are therapeutically relevant changes in serum phenobarbital concentrations throughout a daily dosing interval in epileptic dogs receiving phenobarbital for ≥ 3 weeks.

Design—Prospective study.

Animals—33 epileptic dogs receiving phenobarbital.

Procedure—Serum phenobarbital concentrations were measured at 0 hour (trough), 3 hours, and 6 hours after oral administration of phenobarbital in epileptic dogs that had received phenobarbital twice daily for a minimum of 3 weeks. For each dog, trough, 3-hour, and 6-hour serum phenobarbital concentrations were evaluated to determine whether they were within the same therapeutic category (lower, middle, or upper end of the therapeutic range of 15 to 45 µg/ml), or whether there was a > 30% change in serum concentrations throughout the day.

Results—Ninety-one percent (30/33) of dogs had trough, 3-hour, and 6-hour serum phenobarbital concentrations in the same therapeutic category. Only 9% (3/33) of dogs had trough, 3-hour, and 6-hour serum concentrations in different therapeutic categories with a > 30% change in concentrations throughout the day. Significant differences were not detected among mean serum phenobarbital concentrations when comparing the trough, 3-hour, and 6- hour samples for all dogs.

Conclusions and Clinical Relevance—There is no therapeutically relevant change in serum phenobarbital concentrations throughout a daily dosing interval in most epileptic dogs. Therefore, timing is not important when collecting blood samples to measure serum phenobarbital concentrations in most epileptic dogs treated long-term with phenobarbital. (J Am Vet Med Assoc 2000;217:200–204)

Restricted access
in Journal of the American Veterinary Medical Association